Drug copayments matter
Austin Frakt December 5, 2011
I want to quickly note that on this blog we’ve covered the effect of drug copayments on patients’ adherence to drug regimens: Many people in
I want to quickly note that on this blog we’ve covered the effect of drug copayments on patients’ adherence to drug regimens: Many people in
BPC: Is Premium Support the Answer? Dec 16, 10-11:30am @Brookings Inst. RWJF: vote for the most influential health research publication of 2011 Today in TIE:
I’ve been getting quite a bit of email since Harold’s post on Saturday. A number of you have asked why I’m not irate, and why
One way to violate the very thing I highlighted in my prior post (standards of good attribution) is to quote someone and leave out a part
Some people don’t quite get how blogging is different from other writing. Dan Frommer does and he has some advice on how to blog better.
In the Philips Electronics & Nokia cases, the European Court of Justice recently affirmed that patents and trademarks are not enforced against goods in-transit through
One of the things I like most about blogging is that it constantly forces me to question my assumptions. Writing so much, and reading so
The CDC has released a report on prescription painkiller overdoses in the US. “One in 20 people in the United States, ages 12 and older, used prescription
It has been fascinating to show people the CHRT‘s chart of how people would get health insurance under the ACA, and to listen to what
A good rule of thumb is that if David Cutler doesn’t know something about our health system nobody does. In his latest paper, coauthored by Fabian
Work posted here under copyright © of the authors • Details on the Site Policies page
